Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3629-3631
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3629
Cognitive clarity in colon surgery: The dexmedetomidine advantage
Asad G Rao, Abdulqadir J Nashwan
Asad G Rao, Department of Clinical Medicine, Dow Medical College, Karachi 74200, Pakistan
Abdulqadir J Nashwan, Department of Nursing and Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar
Author contributions: Rao AG and Nashwan AJ wrote the draft and critically reviewed the literature.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Abdulqadir J Nashwan, MSc, PhD, Research Scientist, Department of Nursing and Midwifery Research, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa
Received: July 23, 2024
Revised: October 10, 2024
Accepted: October 14, 2024
Published online: November 27, 2024
Processing time: 99 Days and 10.2 Hours
Core Tip

Core Tip: This letter highlights the trial by Bu et al, which reveals that dexmedetomidine can significantly reduce the incidence of postoperative cognitive dysfunction and improve cerebral oxygenation in elderly patients undergoing radical colon cancer surgery. Despite several limitations, the study reflects profound clinical implications while suggesting additional research and innovative approaches to treatment.